What is the equity of Baudax Bio this year?
Baudax Bio has equity of -24.24 M USD this year.
Baudax Bio Equity 2024
Baudax Bio Equity
-24.24 M USD
Ticker
BXRX
ISIN
US07160F1075
WKN
A2PU9U
In 2024, Baudax Bio's equity was -24.24 M USD, a -283.22% increase from the 13.23 M USD equity in the previous year.
Baudax Bio Aktienanalyse
What does Baudax Bio do?
Baudax Bio Inc is a leading biotechnology company that provides innovative products and solutions to improve human health. The company was founded in 2019 and is headquartered in Malvern, Pennsylvania. It is listed on the NASDAQ Capital Market. Baudax Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Baudax Bio's Equity
Baudax Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Baudax Bio's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Baudax Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Baudax Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Baudax Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Baudax Bio stock
What was the equity of Baudax Bio compared to the previous year?
The equity of Baudax Bio has increased/decreased by -283.22% decreased compared to the previous year.
What impact does a high equity have on investors of Baudax Bio?
A high equity is advantageous for investors of Baudax Bio as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Baudax Bio?
A low equity can be a risk for investors of Baudax Bio, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Baudax Bio affect the company?
An increase in equity of Baudax Bio can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Baudax Bio affect the company?
A reduction in equity of Baudax Bio can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Baudax Bio?
Some factors that can affect the equity of Baudax Bio include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Baudax Bio so important for investors?
The equity of Baudax Bio is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Baudax Bio take to change the equity?
To change equity, Baudax Bio can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Baudax Bio pay?
Over the past 12 months, Baudax Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Baudax Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of Baudax Bio?
The current dividend yield of Baudax Bio is .
When does Baudax Bio pay dividends?
Baudax Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Baudax Bio?
Baudax Bio paid dividends every year for the past 0 years.
What is the dividend of Baudax Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Baudax Bio located?
Baudax Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Baudax Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Baudax Bio from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did Baudax Bio pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of Baudax Bio in the year 2023?
In the year 2023, Baudax Bio distributed 0 USD as dividends.
In which currency does Baudax Bio pay out the dividend?
The dividends of Baudax Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Baudax Bio
Our stock analysis for Baudax Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Baudax Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
